Sale!

DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test

Original price was: KSh 56,000.Current price is: KSh 40,000.

-29%

The DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test is vital for diagnosing conditions related to Primary Ciliary Dyskinesia (PCD), a genetic disorder affecting the cilia in the respiratory system. This test helps identify mutations in the DNAAF1 gene, which can lead to chronic respiratory issues and ear, nose, and throat (ENT) disorders. Priced at KSh 56,000, it offers significant insights into genetic predispositions and aids in effective management of symptoms.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 0711564616
Guaranteed Safe Checkout

DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test
DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test
KSh 56,000 Original price was: KSh 56,000.KSh 40,000Current price is: KSh 40,000.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test

Introduction to the Test

The DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test is a cutting-edge diagnostic tool that plays a crucial role in understanding and diagnosing Primary Ciliary Dyskinesia (PCD). PCD is a genetic disorder that affects the cilia, the tiny hair-like structures responsible for clearing mucus and pathogens from the respiratory tract. This test utilizes Next Generation Sequencing (NGS) technology to detect mutations in the DNAAF1 gene, which is essential for proper ciliary function.

What the Test Measures

This test specifically measures the presence of mutations in the DNAAF1 gene, which can lead to dysfunctional cilia. By identifying these genetic variations, healthcare providers can better understand the underlying causes of respiratory issues and other related symptoms.

Who Should Consider This Test?

Individuals experiencing chronic respiratory infections, persistent cough, or recurrent ear, nose, and throat disorders should consider this test. Additionally, those with a family history of PCD or related genetic conditions may benefit from genetic testing to determine their risk factors.

Benefits of Taking the Test

  • Accurate diagnosis of Primary Ciliary Dyskinesia.
  • Informed management of symptoms and treatment options.
  • Understanding of genetic predispositions and family planning.
  • Access to specialized care from ENT doctors and genetic counselors.

Understanding Your Results

Upon completion of the test, results will be analyzed and interpreted by qualified professionals. A positive result indicates the presence of mutations in the DNAAF1 gene, which may require further clinical evaluation and management. Patients will receive guidance on the implications of their results and the next steps in their care.

Test Pricing

Test Name Discount Price (KSh) Regular Price (KSh)
DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test 40,000 56,000

Our Services

We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu, making it easy for you to access our services. We also offer home sample collection for your convenience.

Book Your Test Today!

Don’t wait to get the answers you need. Book your DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test today! For inquiries or to schedule your appointment, call or WhatsApp us at +254711564616.